Products - Head and neck cancers | Topic | NICE

Showing 3 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Atezolizumab for adjuvant treatment of high-risk locally advanced squamous cell head and neck cancer [ID4052]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Xevinapant with platinum-based chemotherapy and radiotherapy for untreated locally advanced squamous cell head and neck cancer [ID6199]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Leukocyte interleukin in combination for neoadjuvant treatment of resectable locally advanced squamous cell head and neck cancer [ID6390]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC